{
    "profile_id": "benjamin-chalopin-301211139",
    "first_name": "Benjamin",
    "last_name": "Chalopin",
    "sub_title": "Postdoctoral Scientist at Princess Maxima Center",
    "profile_picture": "https://media.licdn.com/dms/image/C4D03AQG4GobKJhNecQ/profile-displayphoto-shrink_400_400/0/1604671649963?e=1701302400&v=beta&t=WmyKxGwG0diZ9tMoIK2-SH2vk1v3Y71ETNV_88MpTgA",
    "background_image": null,
    "profile_type": "personal",
    "entity_urn": "ACoAACGrQXEBSHPpjm3eV2GriAzvbMvzQIVRmzY",
    "object_urn": 564871537,
    "birth_date": null,
    "summary": null,
    "location": {
        "country": null,
        "short": "Netherlands",
        "city": null,
        "state": null,
        "default": "Netherlands"
    },
    "premium": false,
    "influencer": false,
    "treasury_media": [],
    "languages": {
        "primary_locale": {
            "country": "FR",
            "language": "fr"
        },
        "supported_locales": [
            {
                "country": "FR",
                "language": "fr"
            }
        ],
        "profile_languages": []
    },
    "industry": "Think Tanks",
    "education": [
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2015
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2020
                }
            },
            "school": {
                "name": "Nantes Universit\u00e9",
                "logo": "https://media.licdn.com/dms/image/C560BAQGw8SV-x0sJqg/company-logo_400_400/0/1641202756411/universite_de_nantes_logo?e=1703721600&v=beta&t=qXkqw-XJxm4IXARIa-WD0753uGbIceMvKLmRc4KF374",
                "url": "https://www.linkedin.com/school/nantes-universite/"
            },
            "degree_name": "Ph.D.",
            "field_of_study": "Biology, oncology, protein engineering, molecular biology, cellular biology. ",
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2013
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2014
                }
            },
            "school": {
                "name": "Universit\u00e9 d'Angers",
                "logo": "https://media.licdn.com/dms/image/D4E0BAQFQMt41__vnCA/company-logo_400_400/0/1667396622727/univangers_logo?e=1703721600&v=beta&t=plsxv-Wh_a8EscMaoUwKbl6lT0OacYjs9sc2qOpOwo4",
                "url": "https://www.linkedin.com/school/univangers/"
            },
            "degree_name": "Master of science (2nd year)",
            "field_of_study": "Cellular and molecular biology",
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2012
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2013
                }
            },
            "school": {
                "name": "Nantes Universit\u00e9",
                "logo": "https://media.licdn.com/dms/image/C560BAQGw8SV-x0sJqg/company-logo_400_400/0/1641202756411/universite_de_nantes_logo?e=1703721600&v=beta&t=qXkqw-XJxm4IXARIa-WD0753uGbIceMvKLmRc4KF374",
                "url": "https://www.linkedin.com/school/nantes-universite/"
            },
            "degree_name": "Master of science (1st year)",
            "field_of_study": "Biology, oncology, immunology",
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2009
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2012
                }
            },
            "school": {
                "name": "Nantes Universit\u00e9",
                "logo": "https://media.licdn.com/dms/image/C560BAQGw8SV-x0sJqg/company-logo_400_400/0/1641202756411/universite_de_nantes_logo?e=1703721600&v=beta&t=qXkqw-XJxm4IXARIa-WD0753uGbIceMvKLmRc4KF374",
                "url": "https://www.linkedin.com/school/nantes-universite/"
            },
            "degree_name": "Bachelor's degree",
            "field_of_study": "Biology, biochemistry ",
            "grade": null
        }
    ],
    "patents": [],
    "awards": [],
    "certifications": [],
    "organizations": [],
    "projects": [],
    "publications": [],
    "courses": [],
    "test_scores": [],
    "position_groups": [
        {
            "company": {
                "id": 3504927,
                "name": "Prinses M\u00e1xima Centrum voor kinderoncologie",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQGERH4etc8hpQ/company-logo_400_400/0/1532080608473/prinses_m_xima_centrum_voor_kinderoncologie_logo?e=1703721600&v=beta&t=pITXfax5yTNjo6T_WG87G0VhqaRD2wCiH5JVuGo269g",
                "url": "https://www.linkedin.com/company/prinses-m-xima-centrum-voor-kinderoncologie/",
                "employees": {
                    "start": 1001,
                    "end": 5000
                }
            },
            "date": {
                "start": {
                    "month": 6,
                    "day": null,
                    "year": 2023
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "profile_positions": [
                {
                    "location": "Utrecht, Pays-Bas",
                    "date": {
                        "start": {
                            "month": 6,
                            "day": null,
                            "year": 2023
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": null
                        }
                    },
                    "company": "Prinses M\u00e1xima Centrum voor kinderoncologie",
                    "description": "Antibodies engineering",
                    "title": "Postdoctoral Scientist at Princess Maxima Center",
                    "employment_type": "Contract"
                }
            ]
        },
        {
            "company": {
                "id": 162942,
                "name": "CEA",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQEPVql0weI3Qg/company-logo_400_400/0/1677003044348/cea_logo?e=1703721600&v=beta&t=MZqRr1pz0mQUpwXL0W1OgziIdgCGZ1ufx_tEM9jLUuE",
                "url": "https://www.linkedin.com/company/cea/",
                "employees": {
                    "start": 10001,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 10,
                    "day": null,
                    "year": 2021
                },
                "end": {
                    "month": 6,
                    "day": null,
                    "year": 2023
                }
            },
            "profile_positions": [
                {
                    "location": "Paris et p\u00e9riph\u00e9rie",
                    "date": {
                        "start": {
                            "month": 10,
                            "day": null,
                            "year": 2021
                        },
                        "end": {
                            "month": 6,
                            "day": null,
                            "year": 2023
                        }
                    },
                    "company": "CEA",
                    "description": "Principal investigation: anti-SARS-CoV2 mAbs engineering",
                    "title": "Postdoctoral Scientist",
                    "employment_type": "Contract"
                }
            ]
        },
        {
            "company": {
                "id": 8066,
                "name": "Inserm",
                "logo": "https://media.licdn.com/dms/image/C560BAQHY6E3K3IF_fw/company-logo_400_400/0/1641368858913/inserm_logo?e=1703721600&v=beta&t=1CU5F0O3X_7ae-dZ6dZMKlAL81H8AYPzT7qdjbfFbJM",
                "url": "https://www.linkedin.com/company/inserm/",
                "employees": {
                    "start": 10001,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 1,
                    "day": null,
                    "year": 2015
                },
                "end": {
                    "month": 4,
                    "day": null,
                    "year": 2021
                }
            },
            "profile_positions": [
                {
                    "location": "Nantes, Pays de la Loire, France",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 2015
                        },
                        "end": {
                            "month": 4,
                            "day": null,
                            "year": 2021
                        }
                    },
                    "company": "INSERM",
                    "description": "Principal investigation: Development of anti-CD38 Affitins for Positron Emission Tomography (PET) imaging of multiple myeloma. \nAffitins are artificial affinity proteins with low molecular weight that exhibit comparable affinity and specificity to those of antibodies while being highly stable. They are generated by a fully in vitro process named ribosome display which allows the selection of proteins that can bind to a desired ligand. These different characteristics make Affitins excellent candidates for a use in imaging as an alternative to antibodies. We genetically engineered and characterized Affitins specific for CD38 protein, a marker for multiple myeloma cells. This work is still ongoing and will be followed by the preclinical evaluation of anti-CD38 Affitins. An imaging study based on the use of an anti-CD38 antibody radiolabelled with copper 64 has also been conducted in a murine model of myeloma. The objective was to shed a first light on CD38 targeting for imaging.",
                    "title": "Ph.D. student",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 8066,
                "name": "Inserm",
                "logo": "https://media.licdn.com/dms/image/C560BAQHY6E3K3IF_fw/company-logo_400_400/0/1641368858913/inserm_logo?e=1703721600&v=beta&t=1CU5F0O3X_7ae-dZ6dZMKlAL81H8AYPzT7qdjbfFbJM",
                "url": "https://www.linkedin.com/company/inserm/",
                "employees": {
                    "start": 10001,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 9,
                    "day": null,
                    "year": 2013
                },
                "end": {
                    "month": 9,
                    "day": null,
                    "year": 2014
                }
            },
            "profile_positions": [
                {
                    "location": "Nantes, Pays de la Loire, France",
                    "date": {
                        "start": {
                            "month": 9,
                            "day": null,
                            "year": 2013
                        },
                        "end": {
                            "month": 9,
                            "day": null,
                            "year": 2014
                        }
                    },
                    "company": "INSERM",
                    "description": "Principal investigation: Epigenetic study of meloe gene, encoding for melanoma associated antigens. \nWe previously characterized two melanoma antigens MELOE-1 and MELOE-2 derived from a polycistronic RNA overexpressed in the melanocytic lineage. This transcription profile was due to hypomethylation of meloe proximal promoter in melanomas and melanocytes. In this study we investigated whether this demethylation was restricted to meloe promoter or was linked to a general lack of methylation at meloe locus in the melanocytic lineage. We established the methylation pattern of the locus spanning more than 40kb, focusing on CpG islands, using DNA bi-sulfite conversion and pyrosequencing. We found that demethylation process specifically observed in the melanocytic lineage, concerns a large promoter area and not the whole meloe locus. This allows updating a tight regulation of meloe transcription in this lineage, suggesting tissue-specific epigenetic mechanisms.",
                    "title": "Master of Science (2nd year) ",
                    "employment_type": null
                }
            ]
        }
    ],
    "volunteer_experiences": [],
    "skills": [],
    "network_info": null,
    "related_profiles": null,
    "contact_info": null
}